David S. Ege

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Thomas J. DesRosier, attorney-in-fact for David S. Ege
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David S. Ege:

Company Role Class Num Shares Value Price $ Report Date Ownership
Seres Therapeutics, Inc. Executive Vice President and Chief Technology Officer Common Stock 77,575 $65,163 $0.8400 16 Aug 2024 Direct
Seres Therapeutics, Inc. Executive Vice President and Chief Technology Officer Restricted Stock Units 29,688 $32,179 $1.08 15 Aug 2024 Direct
Seres Therapeutics, Inc. Executive Vice President and Chief Technology Officer Stock Option (Right to Buy) 287,905 14 Feb 2024 Direct

Insider Reports Filed by David S. Ege

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MCRB Seres Therapeutics, Inc. 15 Aug 2024 3 -$948 4 Executive Vice President and Chief Technology Officer 19 Aug 2024, 17:29
MCRB Seres Therapeutics, Inc. 15 May 2024 3 -$1,025 4 Executive Vice President and Chief Technology Officer 17 May 2024, 20:16
MCRB Seres Therapeutics, Inc. 14 Feb 2024 6 -$5,411 4 Executive Vice President and Chief Technology Officer 16 Feb 2024, 21:15
MCRB Seres Therapeutics, Inc. 27 Oct 2023 4 -$5,489 4 Executive Vice President and Chief Technology Officer 31 Oct 2023, 21:39
MCRB Seres Therapeutics, Inc. 27 Apr 2023 2 -$36,527 4 Executive Vice President and Chief Technology Officer 01 May 2023, 16:46
MCRB Seres Therapeutics, Inc. 03 Feb 2023 2 $0 4 Executive Vice President and Chief Technology Officer 07 Feb 2023, 16:50
MCRB Seres Therapeutics, Inc. 27 Oct 2022 2 -$39,745 4 Executive Vice President and Chief Technology Officer 31 Oct 2022, 19:37
MCRB Seres Therapeutics, Inc. 05 Jul 2022 1 +$100,000 4 Executive Vice President and Chief Technology Officer 06 Jul 2022, 19:22
MCRB Seres Therapeutics, Inc. 04 Feb 2022 1 $0 4 Executive Vice President and Chief Technology Officer 08 Feb 2022, 20:30